XML 22 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders Equity (Deficit) - USD ($)
$ in Thousands
Total
IPO
Redeemable Convertible Preferred Stock
Redeemable Convertible Preferred Stock
IPO
Common Stock
Common Stock
IPO
Additional Paid-in Capital
Additional Paid-in Capital
IPO
Retained Earnings
Beginning Balance, Amount at Dec. 31, 2020 $ (88,849)       $ 9   $ 1,183   $ (90,041)
Beginning Balance, shares at Dec. 31, 2020     12,767,202            
Balance at December 31, 2020 at Dec. 31, 2020     $ 117,331            
Balance at December 31, 2020 at Dec. 31, 2020         9,509,182        
Conversion of redeemable convertible preferred stock to common stock upon initial public offering, Shares       (12,767,202)   25,534,404      
Conversion of redeemable convertible preferred stock to common stock upon initial public offering   $ 117,331   $ 117,331   $ 26   $ 117,305  
Issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions and other offering costs of $23.8 million, Amount 252,174       $ 12   252,162    
Issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions and other offering costs of $23.8 million, Shares         11,500,000        
Conversion of redeemable convertible preferred stock warrants to common stock warrants upon initial public offering, Amount 8,973           8,973    
Exercise of common stock warrants, Amount 0       $ 1   (1)    
Exercise of common stock warrants, Shares         483,554        
Exercise of stock options, Amount 355           355    
Exercise of stock options, Shares         477,564        
Stock-based compensation expense 5,083           5,083    
Net loss attributable to common stockholders (62,960)               (62,960)
Ending Balance, Amount at Dec. 31, 2021 232,107       $ 48   385,060   (153,001)
Ending Balance, shares at Dec. 31, 2021     0            
Balance at September 30, 2021 at Dec. 31, 2021     $ 0            
Balance at September 30, 2021 at Dec. 31, 2021         47,504,704        
Exercise of stock options, Amount $ 672           672    
Exercise of stock options, Shares 683,482       98,924        
Stock-based compensation expense $ 12,963           12,963    
Issuance of common stock upon exercise of stock options (In Shares)         683,482        
Issuance of common stock upon exercise of stock options 576           576  
Issuance of common stock upon vesting of restricted stock units (In Shares)         11,028        
Net loss attributable to common stockholders (86,242)               (86,242)
Ending Balance, Amount at Dec. 31, 2022 $ 160,076       $ 48   $ 399,271   $ (239,243)
Balance at September 30, 2021 at Dec. 31, 2022         48,298,138